We are live on
!
Find out more
MAM
MPM Asset Management Portfolio holdings
AUM
$44.5M
1-Year Est. Return
47.28%
This Fund
S&P 500
This Quarter
Est. Return
+5.51%
1 Year Est. Return
-47.28%
3 Year Est. Return
+5.89%
5 Year Est. Return
-18.52%
10 Year Est. Return
+3.53%
AUM
$236M
AUM Growth
-$73.4M
(-24%)
Cap. Flow
-$88.9M
Cap. Flow
% of AUM
-37.61%
Top 10 Holdings %
Top 10 Hldgs %
99.67%
Holding
14
New
2
Increased
–
Reduced
6
Closed
2
Top Buys
| 1 |
EIGR
Eiger BioPharmaceuticals, Inc.
EIGR
|
+$11.2M |
| 2 |
Savara
SVRA
|
+$411K |
Top Sells
| 1 |
PTLA
Portola Pharmaceuticals, Inc.
PTLA
|
+$32.6M |
| 2 |
PETX
Aratana Therapeutics, Inc.
PETX
|
+$31.3M |
| 3 |
EPZM
Epizyme, Inc
EPZM
|
+$14.1M |
| 4 |
KBIO
KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE)
KBIO
|
+$11.6M |
| 5 |
Pacira BioSciences
PCRX
|
+$4.15M |
Sector Composition
| 1 | Healthcare | 64.72% |
Similar funds
WCPI
BAM
WAMC
NLVP
CIEP
IPI
CC
VSAM